Scribe is building a team with the deepest expertise in engineering, applying, and democratizing access to gene editing technologies for robust use in treating human disease.

Leadership Team

Board of Directors

partners and investors

Scribe’s genome engineering experts collaborate with biopharma industry leaders to develop CRISPR tools specially designed to target the underlying causes of genetic disease and accelerate the production of breakthrough in vivo treatments.

n. an ancient record keeper, one who would also serve the community as copyist, editor, teacher, and jurist
Scribe is a culture dedicated to our community, to each other and to our mission of engineering, applying and democratizing gene editing technologies.